Abstract
Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.
Original language | English (US) |
---|---|
Pages (from-to) | 62-84 |
Number of pages | 23 |
Journal | Patient Care |
Volume | 34 |
Issue number | 13 |
State | Published - 2000 |
ASJC Scopus subject areas
- Leadership and Management